Answers are grounded in this paper and cite their sources.
Background Efficient screening and evaluation of high-producing strains are essential for improving microbial cell factories, particularly for industrial production of valuable secondary metabolites. However, conventional strain screening strategies mainly rely on destructive fermentation sampling and chromatographic quantification, which are time-consuming and provide limited information regarding intracellular metabolic states. Therefore, rapid and non-invasive phenotypic approaches capable of monitoring metabolite accumulation at the single-cell level are highly desirable. Results We developed a live-cell metabolic phenotyping platform that enables rapid evaluation of tetracycline-producing Streptomyces aureofaciens strains through intracellular fluorescence imaging. The platform integrates a tetracycline-responsive molecular beacon with cell-penetrating peptide-assisted intracellular delivery, allowing visualization of intracellular tetracycline accumulation in living intact cells without cell lysis or metabolite extraction. The fluorescence response exhibited a concentration-dependent correlation with tetracycline production and reflected dynamic changes in intracellular antibiotic accumulation during fermentation. By applying this imaging-based phenotyping strategy to different industrial S. aureofaciens strains, high-producing strains were efficiently distinguished according to their intracellular fluorescence signatures. Importantly, fluorescence-based strain ranking showed agreement with HPLC quantification and was further validated through fermentation experiments. Conclusions This study establishes a non-destructive live-cell metabolic phenotyping platform for the phenotypic evaluation and prioritization of industrial microbial strains. By converting intracellular metabolite accumulation into a measurable optical phenotype, this strategy provides cellular-level information complementary to conventional analytical methods and offers a phenotypic prioritization tool that can facilitate microbial cell factory development.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: